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ABSTRACT 18 
 19 
In humans, placebo effect can be produced by giving verbal information and also by 20 
conditioning when, after repeated administration of an active substance, an inactive 21 
compound that just looks like the drug administered before, can produce the effect of the 22 
active substance. Conditioned placebo effect has been reported in rodents, however, the dog 23 
(Canis familiaris) may also provide a promising model species. In our study dogs’ behaviour 24 
was observed while they were repeatedly separated from their owners in the same unfamiliar 25 
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room. First, subjects did not receive any pre-treatment (Baseline trial), then they participated 26 
in either of two different conditioning contexts: after having received either sedative drug 27 
(Conditioned group) or non-sedating vitamin (Control group) treatment, subjects participated 28 
in 3 conditioning trials on consecutive days. Finally, in the ‘Test trial’, both groups were 29 
separated from their owners after receiving placebo (non-sedating vitamin). Results show 30 
significant effect of the sedative drug conditioning; when comparing the change from 31 
Baseline to Test trials in the Conditioned and the Control group, conditioned subjects showed 32 
less active signs of distress (U(26)=48, p=0.021) and more passive behaviours (U(26)=50, 33 
p=0.027). We also investigated the association between dogs’ susceptibility to conditioned 34 
placebo effect and their expectancy bias towards positive outcomes and found a positive 35 
correlation (r(12)= 0.697 p = 0.008), suggesting that dogs with more positive expectations are 36 
more responsive to placebo treatment. Considering previous human findings about stronger 37 
responsiveness to placebo in optimistic people, our results support the validity of the 38 
application of a dog model towards a better understanding of some aspects of the placebo 39 
phenomena in humans. 40 
 41 
Keywords: placebo-effect, conditioning, dog, expectancy, cognitive bias 42 
 43 
Highlights:  44 
Dogs can be a useful model species for studying the placebo phenomenon. 45 
Results showed evidence of the conditioned placebo-effect in dogs. 46 
Sedative drug conditioning affects later behaviour in the Strange Situation Test. 47 
There is a relationship between individual placebo response and positive expectancy. 48 
49 
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1. INTRODUCTION 50 
 51 
 Investigation of the mechanisms as well as the behavioural and psychological 52 
dimensions of the placebo effect has become a burgeoning field of life sciences in the last few 53 
decades. According to the widely accepted definition, placebo is a substance or procedure that 54 
has no inherent power to produce an effect that is sought or expected (Stewart-Wiliams and 55 
Podd, 2004). The effect that placebos have can be highly variable involving both 56 
psychological and physiological changes (e.g. endogenous opiate release Petrovic et al., 2002, 57 
Wager et al., 2004). 58 
 Nevertheless, placebo effect is often conceptualized as a psychosocial context effect 59 
(Benedetti et al., 2004) involving the formation of cognitive expectancies, a process driven by 60 
verbal information from a trustworthy, certified person (Benedetti et al., 1999; 2003). 61 
Although this view would strongly suggest that placebo effects are limited to humans, 62 
experimental evidence indicates that this complex phenomenon stems from both higher 63 
mental functions and lower conditioning effects, and thus can also be studied in nonhuman 64 
subjects (see Price et al., 2008 for a review). 65 
 Increasing evidence suggests that placebo responses can be formed by classical 66 
conditioning in both humans (Voudouris et al., 1990) and different species of animals 67 
(McMillan 1999). This process is based on the association between an active substance 68 
(unconditioned stimulus) and some characteristic property of the substance (smell, taste, 69 
colour) and/or some environmental cues (places, persons, procedures, rituals) surrounding the 70 
treatment (conditioned stimuli). After repeated experience of the specific effects of the 71 
treatment, a procedure with the same features but without the active substance can produce 72 
the very same physiological and/or behavioural effects evoking a conditioned response. The 73 
induction of a placebo effect via conditioning is possible even when the effect of the treatment 74 
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is unconscious and imperceptible to the subject (e.g. change in hormone level - Benedetti et 75 
al., 2003 or immune response - Goebel et al., 2002). 76 
 In addition to rats and other laboratory rodents that are often used to demonstrate the 77 
conditioned placebo effect (see Stewart-Williams and Podd, 2004 for a review), some 78 
evidence suggests a placebo-like effect in pet dogs that have undergone veterinary treatment. 79 
However, it is important to note that in all placebo studies on dogs, assessment of the 80 
magnitude of placebo responses has been based solely on the owners’ subjective evaluation; 81 
therefore, the results could be strongly influenced by the owners’ expectations (Muñana et al., 82 
2010; Jaeger et al., 2005). Although the mechanism mediating the effects of placebo treatment 83 
in dogs is still unclear, Cracknell and Mills (2008) investigated the role placebo treatment 84 
plays in overcoming fear and anxiety. They found a significant anxiolytic effect in dogs that 85 
showed excessive fear response to fireworks. This result was also based on owners’ reports, 86 
so further confirmation of conclusions about the role of placebo in alleviating fear or relieving 87 
pain would require the collection of behavioural data through direct observations.  88 
These findings are in line with the increasing evidence of dogs’ human-tuned social 89 
cognitive skills (Kaminski, 2008) and support the idea that the fear/anxiety-alleviating effect 90 
of placebo treatment in dogs is a phenomenon worth investigating within the context of the 91 
dog-human social bond. It has been suggested that dogs possess a specific behaviour 92 
organising mechanism (called interspecific attachment), which evokes specific responses in 93 
stress situations related to separation from the attachment figure (see Topál and Gácsi, 2012 94 
for a review). Separation related behaviours, the fear or dislike of isolation from the owner 95 
even in familiar environments, are frequently reported problems in pet dogs (Wright and 96 
Nesselrote, 1987). Behaviour symptoms associated with physiological changes (Palestrini et 97 
al., 2010) can be reduced by medication or behaviour therapy (Butler et al., 2011; Appleby 98 
and Plujimakers, 2004). Concerning the medication to treat anxiety disorders in dogs, Sedalin 99 
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is one of the widely used psychoactive drugs. Its active substance is acetylpromazine, which 100 
has a tranquilizing effect (Booth, 1991) as it causes a general depression of the nervous 101 
system characterised by both neuronal and behavioural changes (Tontodonati et al., 2007). 102 
 The most widely used experimental paradigm to study dog-human attachment and 103 
separation anxiety is the Strange Situation Test (SST), which capitalizes on the tendency of 104 
dogs to show specific behaviours when separated from the owner in an unfamiliar room 105 
(Topál et al., 1998). In this context, efforts to re-establish the proximity (scratching the door, 106 
orientation to the door, vocalisation) are typical characteristics of dogs’ behaviour (e.g. Prato-107 
Previde et al., 2003; Palmer and Custance, 2008). 108 
 Although behavioural manifestations of separation anxiety in dogs are easy to observe 109 
and behavioural symptoms of anxiety can be reduced by tranquilizers, placebo conditioning 110 
studies are missing. Thus, in the first experiment of the present study we aimed to investigate 111 
the role of placebo in reducing dogs’ separation related distress behaviours and to determine 112 
whether it is possible to produce a conditioned placebo-effect after repeated experiences of 113 
the anxiolytic effects of psychoactive drug (Sedalin) treatment in the experimental situation.  114 
Moreover, since responsiveness to expectancy based placebo treatment in humans is 115 
positively affected by subjects’ dispositional optimism (Geers et al., 2005; 2007; 2010; 116 
Morton et al., 2009), in a follow up study (Experiment 2) we aimed to test whether individual 117 
differences in dogs’ susceptibility to the placebo effect are linked to the subjects’ tendency to 118 
form positive expectations about upcoming events.  119 
Discrimination learning tasks are standardly used to assess positive expectation bias in 120 
non-human animals (Harding et al., 2004) including rats (Burman et al., 2009), sheep (Doyle 121 
et al., 2010), starlings (Bateson and Matheson, 2007), and honeybees (Bateson et al., 2011). 122 
After the subjects have learned that one stimulus (sound, colour, location, etc.) is negative 123 
(non-reinforced), while another one is positive (reinforced) they typically respond with higher 124 
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latency to the negative stimulus. When subjects are presented with an ambivalent stimulus 125 
(transition between negative and positive stimuli), “optimistic” subjects respond as if they 126 
were presented with the positive stimulus (Mendl et al., 2009). This method was successfully 127 
applied for dogs with location cues (Mendl et al., 2010; Müller et al., 2012) and in colour 128 
discrimination contexts (Burman et al., 2011).  129 
In the present study we hypothesised that there would be a significant positive correlation 130 
between dogs’ susceptibility to placebo conditioning (measured by the relative change in 131 
behaviour signs of distress -  Experiment 1), and their positive expectation bias scores 132 
(measured by Mendl et al.’s 2010 discrimination learning task - Experiment 2).  133 
 134 
2. MATERIALS AND METHODS 135 
 136 
2.1. Experiment 1: Conditioned placebo effect 137 
 138 
2.1.1. Subjects 139 
 Participants were recruited on a voluntary basis. Owners completed a brief 140 
questionnaire about their dog’s behaviour during different separation situations, and those 141 
dogs that were affected in at least 3 out of the 7 contexts, and were reported to show 142 
behavioural problems (e.g. excessive barking, salivating, destructive behaviour) when left 143 
alone in an unfamiliar place were selected. An additional criterion for selection was that the 144 
dog was not taking any medication and had no known health problem. All owners were 145 
provided with adequate information about the effects of Sedalin and they signed the informed 146 
consent form to participate. However, owners were not informed of the specific aims and 147 
design of the study, and they did not know if their dogs had been given Sedalin or vitamin 148 
before the trials. The procedure was approved by the Ethical Committee for Animal 149 
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Experimentation of Eötvös University (No. XIV-I-001/521-4/2012), and conducted in 150 
accordance with the national laws regulating animal research. 151 
Thirty-one adult (> 1 year) pet dogs were included in the experiment, but 3 owners and their 152 
dogs did not come back to all trials. The remaining 28 dogs (mean age±SD: 1.8±3.09 years, 153 
15 males and 13 females from 13 different breeds and 13 mongrels) were tested and included 154 
in the data analysis. Subjects were randomly assigned to either the Conditioned or the Control 155 
group (N= 14-14). The two groups did not differ in their mean age (t(26)=0.905, p=0.374), sex 156 
ratio (χ2(1)=0.144, p=0.705), breed distribution (χ2(7)=3.0, p=0.885), body weight (t(26)=0.786, 157 
p=0.439), separation anxiety questionnaire score (U(26)=84, p=0.541) and in terms of duration 158 
from baseline to test trial (t(26)=1.047, p=0.305), and duration from the last conditioning event 159 
to test trial (t(26)=0.0, p>0.999). 160 
 161 
2.1.2. Experimental arrangement 162 
 The experiment took place in a room (3.9 m x 4.1 m) at the Family Dog Project lab, at 163 
Eötvös University, Budapest. Only a chair and some toys for the dog were placed in the room. 164 
Two different doors were used by the two human participants, the owner and the stranger 165 
(Figure 1). The stranger was always a woman who was unfamiliar to the dogs. 166 
 167 
2.1.3. Procedure 168 
Dogs participated in five trials, taking 1-4 day breaks (at least 24 hours) between them. 169 
 170 
Baseline trial  171 
 The procedure was identical for both groups. Subjects participated in a modified and 172 
shortened version of Strange Situation Test (Topál et al., 1998). It consisted of 3 episodes, 173 
each lasting for 2 minutes. Human participants (owner and stranger) followed detailed 174 
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instructions that determined their behaviour during the test. The three episodes were preceded 175 
by a short introductory phase during which the experimenter introduced the dog and the 176 
owner to the experimental room through Door 2, and the dog was allowed to explore the room 177 
for 30 s. Then, the experimenter left the room with the owner through Door 2. 178 
 The episodes followed each other in a fixed order: the dog was 1) alone, 2) with a 179 
stranger, 3) with the owner in the experimental room.  180 
Episode 1: Dog alone  181 
The dog was left alone, and observed by the owner and experimenter on the monitor in the 182 
adjacent room (without speaking, thus the dog could not hear people in the adjacent room). 183 
Episode 2: Dog & Stranger  184 
The stranger entered the room (through Door 1), stepped up to a predetermined point (SP) and 185 
stood there for 1 minute. She adjusted her behaviour to that of the dog (petted its head and 186 
back if the dog initiated contact) and tried to keep the dog away from the doorway by playing 187 
or petting (depending on the preference of the dog). After 1 minute, she sat on the chair and 188 
stopped playing. During the second minute she was allowed to pet the dog if it initiated 189 
contact. 190 
Episode 3: Dog & Owner 191 
The owner entered the room through Door 2 and stepped up to a predetermined point. 192 
Meanwhile, the stranger left through Door 1. The owner then greeted and comforted the dog 193 
(petting and playing – depending on the dog’s reaction). The owner stood at the 194 
predetermined point (OP) until the end of the episode, playing with and/or petting the dog if it 195 
initiated. 196 
 197 
Conditioning trials (2-4) 198 
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 In case of the three conditioning trials, 25 minutes before each trial, dogs received 199 
either a sedative drug (Sedalin Gel Oraldoser A.U.V. manufactured by Vetoquinol Biowet 200 
Sp.z.o.o., dose: 1 ml/35 kg body weight) in a piece of liverwurst (approx. 10 g, manufactured 201 
by Szegedi Paprika Zrt.) or a non-sedating vitamin formulation (dose: 1 ml/35 kg body 202 
weight, Canigest Paste manufactured by TRM Pet Products) in a piece of liverwurst. Sedalin 203 
is widely applied by veterinarians as tranquilizer and anesthetic premedicant; it shows effects 204 
in 20 minutes and lasts 6-12 hours. The vitamin did not have any effect during the 205 
experiments. Dogs received the treatment in the kitchen of the department and spent the 25 206 
minutes there resting next to the owner. 207 
 In order to increase the saliency of ‘treatment’ and to facilitate the formation of 208 
associations between the physiological effects of pre-trial treatment and the unfamiliar test 209 
environment, we introduced an additional salient treatment right before the conditioning trials 210 
in both groups. The experimenter sprayed the dogs’ muzzle and paws with clear water (using 211 
a hand pump spray bottle) and during the spraying she gave one more piece of liverwurst to 212 
the dog. 213 
 Conditioning trials included three episodes similar to the Baseline, however, the owner 214 
was present with the dog in all three episodes in order to avoid any possibility of separation 215 
from the owner being directly associated with the anxiolytic effects of Sedalin. Episodes 1 216 
and 3 were identical to episode 3 in the Baseline trial. In episode 2, in contrast to the Baseline 217 
trial, the owner did not leave but was standing at the predetermined point and was allowed to 218 
interact with the dog while the stranger was in the room. 219 
 220 
Test trial 221 
 In the test trial, all dogs were treated similarly. Both groups received placebo (vitamin 222 
treatment) in a piece of liverwurst 25 minutes before the trial. Their muzzles/paws were 223 
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sprayed with water and they received one more piece of liverwurst right before the trial (Table 224 
1). The procedure of this trial was identical to that described in the Baseline. 225 
After the conditioning trials and test trial the owners’ opinion about the type of treatment 226 
(Sedalin or placebo) their dogs received was asked. 227 
 228 
2.1.4. Behaviour coding 229 
 As behaviours related to separation anxiety are typically displayed close to the 230 
exit/entry door (see e.g. Prato-Previde et al. 2003, Palmer and Custance 2008, Palestrini et al. 231 
2005), we recorded the durations of anxiety-related behaviours while staying close (< 1 m) to 232 
the doors. The two doors were not differentiated because both could be considered as a 233 
potential exit by the dogs. On the other hand to examine the sedative effect of the drug the 234 
time spent passively was also measured. Relative durations were recorded for both variables.  235 
Definitions of the behaviour categories: 236 
 Passive behaviours: standing, sitting or lying down anywhere but at the door while alone 237 
(PASS-A), in the presence of the stranger (PASS-S), or in the presence of the owner (PASS-238 
O). 239 
 Door-distress: displaying behavioural signs of distress while staying close to the door; 240 
active behaviours resulting in physical contact with the door (scratching, jumping at etc.) 241 
and/or vocalising (i.e. barking, growling, howling, whining) in the close proximity (< 1 m) of 242 
the door while alone (D/DISTR-A), in the presence of the stranger (D/DISTR-S), or in the 243 
presence of the owner (D/DISTR-O). 244 
 Door-passive: staying (standing, sitting, or lying down) in the close proximity of the door 245 
(< 1 m) without physical contact with it, and/or vocalisation while alone (D/PASS-A), in the 246 
presence of the stranger (D/PASS-S), or in the presence of the owner (D/PASS-O). 247 
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Inter-observer agreement was assessed by parallel evaluation of the behaviour of 20% of the 248 
total sample by two independent coders who were blind to the conditions. The analysis of 249 
inter-observer agreement yielded a very good inter-observer reliability (Cohen’s kappa 250 
values; PASS: 0.92, D/DISTR: 0.87, D/PASS: 0.91). 251 
 252 
2.1.5. Data analysis 253 
 The relative percentage of the time spent in the above behaviours was calculated for the 254 
statistical analyses. Variables did not have Gaussian distribution (Kolmogorov Smirnoff test). 255 
At first we analysed the data with Generalized Estimating Equation (GEE) which is an 256 
extension of the GLM algorithm to accommodate the modelling of repeated measurement 257 
following non-normal distribution (Hardin & Hilbe, 2003). We employed a GEE analysis to 258 
examine the effect of the trial (1
st
, 2
nd
, 3
rd
 conditioning and test trials) as within-subject factor 259 
and the effect of the group (conditioned vs control) as between subject-factor on the owners’ 260 
opinion about the treatment. GEE analysis was also employed to examine the effect of the 261 
repetition (1
st
, 2
nd
 and 3
rd
 conditioning trials) as within-subject factor and the effect of the pre-262 
treatment (administering Sedalin vs. vitamin) as between subject-factor on passive behaviour 263 
of dogs during the Conditioning trials. To analyse the effect of the conditioning we used GEE 264 
analysis to examine the effect of the trial (baseline vs. test) as within-subject factor and the 265 
effect of the pre-treatment (administering Sedalin vs. vitamin) during the Conditioning trials 266 
as between subject-factor on the dogs’ behaviour. When GEE analysis revealed significant 267 
trial x treatment interaction, we calculated the change in the dogs’ behaviours from Baseline 268 
to Test trials. We assumed that the difference in the relative durations of separation distress 269 
related behaviours expressed by the Sedalin conditioned dogs would be an indicator of 270 
subjects’ susceptibility to the placebo effect. We subtracted the relative duration (time%) of a 271 
given behaviour in Baseline from the relative duration of that behaviour in Test trial. The 272 
12 
 
‘difference values’ of the Conditioned and Control groups were compared with Mann-273 
Whitney U tests. 274 
SPSS version 18 software was used for statistical analyses. 275 
 276 
2.2. Experiment 2: Cognitive bias  277 
 278 
2.2.1. Subjects 279 
 Twenty-one dogs (mean age±SD: 3.3±2.02 years, 11 males and 10 females, from 9 280 
different breeds and 8 mongrels) from the 28 subjects that participated in Experiment 1 were 281 
called back for Experiment 2, 1-26 months after the first experiment. (One dog from the 282 
Conditioned group and six dogs from the Control group of Experiment 1 were not available 283 
any more.) 284 
 285 
2.2.2. Procedure 286 
 The procedure was based on the study of Mendl et al. (2010). The Cognitive Bias Test 287 
was conducted in the same room as Experiment 1, the owner and an experimenter were 288 
present with the dog throughout the test. At the start of each trial, the owner led the dog to the 289 
starting position while the experimenter, standing behind the dog and the owner, baited (or 290 
did not bait, depending on trial type) a plastic pot (11cm high, 14 cm in diameter) with a piece 291 
of sausage (see Figure 5).  292 
 293 
Training trials 294 
 Dogs were first trained that, when the pot was placed at one (‘positive’- P) location, it 295 
contained food, and when it was placed at another (‘negative’- N) location, it was empty. The 296 
locations were equidistant from the dog. For 11 dogs, P location was on the right hand side, 297 
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and for 10 dogs it was on the left. The training always started with four warm up trials; two P 298 
trials (baited pot placed at the P location), when dogs could see the baiting, and two N trials 299 
(non-baited pot placed at the N location), in which the experimenter showed the empty 300 
container to the dog. 301 
 Subsequently, P and N training trials were presented in a pseudorandom order, with no 302 
more than two trials of the same type being presented consecutively. Importantly however, in 303 
these trials, dogs were prevented from witnessing whether the container was baited or not, 304 
since the experimenter baited (or not) the pot behind the dog while the owner gently 305 
prevented the dog from looking back. When the experimenter had placed the pot and returned 306 
to her position behind the owner, the dog was released and allowed to choose. Owners were 307 
allowed to encourage their dog (saying “You can go!”). Training trials continued until the 308 
latency for each of the last five N trials was longer than any of the latencies for the last five P 309 
trials. After the dog had reached this learning criterion, the test trials began. 310 
 311 
Test trials 312 
 Testing began once the learning threshold was achieved. Test trials were identical to 313 
training trials except that in three cases the empty pot was placed at the ‘ambivalent’ location 314 
(A) equally spaced between the P and N locations (see Figure 5). The ambiguous trials were 315 
followed by one P and one N trial (9 trials in total; e.g.: APN, ANP, APN) in random order. 316 
 The purpose of the test trials was to investigate how dogs responded to the ambivalent 317 
location and whether they tended to approach them with a speed more similar to that at P 318 
location (indicating anticipation of a food reward – an ‘optimistically’ biased judgement of 319 
the ambivalent cue) or N location, that is, more slowly (indicating lower anticipation of food – 320 
a ‘pessimistically’ biased judgement). 321 
 322 
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2.2.3. Data analysis 323 
 Considering the wide range of time that elapsed between Experiment 1 and 2, we 324 
checked the data for any association with this duration (Pearson correlation test) to determine 325 
if the conditioning of the subjects might have had an effect on the expectancy scores. 326 
The latency to reach the pot was defined as the time that elapsed between being 327 
released by the owner and the moment the dog put its head into the pot, or touched it with its 328 
nose. Latency was recorded for each trial. If the dog did not approach the container within 30 329 
s, the trial was terminated, a latency of 30 s was allocated, and the next trial was initiated. 330 
Mean latencies followed normal distribution (Kolmogorov-Smirnov test). 331 
 Based on the study by Mendl et al. (2010), a positive expectancy score was calculated 332 
for each dog. That is, we adjusted each dog’s mean ambivalent trial latencies (MlatA) by 333 
taking into account its mean ‘baseline’ latencies to get to the positive (MlatP) and negative 334 
(MlatN) locations during the test phase as follows: 335 
 336 
Higher scores indicate stronger positive expectancies. Positive expectancy scores followed 337 
normal distribution (Kolmogorov-Smirnov test). 338 
 Based on the results of Experiment 1, the individual placebo response could be best 339 
indicated by the relative change in the door-distress variable in Episode 1 (D/DISTR-A in the 340 
Baseline vs. Test trial). Higher relative changes are supposed to represent stronger placebo 341 
responses so the relative change of this value was calculated for each dog.  342 
 As the relationship between the placebo response values and positive expectancy 343 
scores was not linear, a logarithmic transformation was made on the placebo response values, 344 
thus the relationship could be analysed with Pearson-correlation. 345 
 346 
3. RESULTS 347 
 
 
100score expectancy positive 



MlatPMlatN
MlatAMlatN
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 348 
3.1. Experiment 1: Conditioned placebo effect 349 
 350 
3.1.1. Dogs’ behaviour during the Conditioning trials 351 
As the owners were present in the experimental room throughout these trials, it is not 352 
surprising that only few dogs (4 in the ‘Conditioned’ and 3 in the ‘Control’ groups) displayed 353 
any behavioural signs of distress. Dogs spent hardly any time with distress behaviours; on 354 
average 0.5% (Sedalin group) and 0.65% (Control group) of the total duration, and, this 355 
remained extremely low even after repeated trials (0.2-1% of time during the 1
st
, 2
nd
 and 3
rd
 356 
conditioning trials in both groups). However, dogs spent much more time with passive 357 
behaviours (on average 31 and 28% in the Conditioned and the Control groups respectively) 358 
and there was no effect of repetition (treatment: χ2= 0.2, p=0.655; repetition: χ2=4.796, 359 
p=0.091). 360 
 361 
3.1.2. Owners’ evaluation of treatment effects 362 
Although we did not find significant effects of Sedalin treatment on the recorded behaviour 363 
variables, the owners in the conditioned group thought more often compared to the control 364 
group that their dog received Sedalin gel in the conditioning trials (GEE analysis, group 365 
effect: χ2=4.023, p=0.045; trial effect: χ2=5.973, p=0.113; interaction: χ2=2.816, p=0.421). 366 
 367 
3.1.3. Dogs’ behaviour in the Test vs. Baseline trials: the effects of conditioning  368 
Separation episode (Episode 1) 369 
 During the separation episode dogs’ passive behaviour was influenced by interaction 370 
between the trial and treatment (GEE, χ2=6.537, p=0.011) with no significant main effects of 371 
the factors (trial: χ2=0.356, p=0.551; treatment: χ2=0.016, p=0.901). The change from 372 
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Baseline to Test trials in the Conditioned group was positive and significantly different from 373 
the slight negative change in the Control group (Mann-Whitney test, U(26)=50, p=0.027) 374 
(Figure 2). Concerning passive behaviours close to the door, however, GEE analysis did not 375 
show significant main effects or interaction (trial: χ2=0.239, p=0.625; treatment: χ2=0.017, 376 
p=0.896; interaction: χ2=1, p=0.317). The analysis of behavioural signs of distress close to the 377 
door showed a significant interaction between the trial and treatment (GEE, χ2=4.66, p=0.031) 378 
with no main effects of trial (Baseline vs. Test: χ2=0.001, p=0.985) or treatment (Sedaline vs. 379 
Vitamin: χ2=0.481, p=0.488) (Figure 3). We found significant difference between changes in 380 
the Conditioned and the Control group (Mann-Whitney test, U(26)=48, p=0.021; Figure 4). 381 
Results of the separation episode are summarized in Table 2. 382 
 383 
Episodes 2 and 3 384 
There were no significant main effects or interactions for any of the behaviour 385 
variables in those episodes when the owner or the experimenter was present (GEE analyses, 386 
PASS-S: trial: χ2=0.232, p=0.627; treatment: χ2=0.052, p=0.819; interaction: χ2=0.609, 387 
p=0.435; D/PASS-S: trial: χ2=0.061, p=0.804; treatment: χ2=0.551, p=0.458; interaction: 388 
χ2=0.055, p=0.815; D/DISTR-S: trial: χ2=0.069, p=0.793; treatment: χ2=2.667, p=0.102; 389 
interaction: χ2=1.736, p=0.188; PASS-O: trial: χ2=2.291, p=0.130; treatment: χ2=0.657, 390 
p=0.418; interaction: χ2=1.863, p=0.172; D/PASS-O: trial: χ2=0.716, p=0.398; treatment: 391 
χ2=0.344, p=0.558; interaction: χ2=2.270, p=0.132); D/DISTR-O: trial: χ2=0.905 p=0.342; 392 
treatment: χ2=0.816, p=0.366; interaction: χ2=1.249, p=0.264). 393 
These results show that the two types of treatment during the conditioning phase of the 394 
experiment affected dogs’ later behaviour differently. After having received treatment with 395 
placebo (non-sedating vitamin) before the Test trial, the behaviour of dogs in the ‘dog alone’ 396 
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episode depended on whether they had been treated with sedative substances during the 397 
conditioning phase. 398 
 399 
3.2. Experiment 2: Cognitive bias 400 
 401 
Subjects reached the training criterion on average after 30 trials (range 12-57 trials), and P 402 
and N locations were strongly differentiated also in the test trials; dogs approached the plastic 403 
pot sooner in P than in N type test trials (paired sample t-test, t(20)=4.036 p<0.001). The 404 
positive expectancy scores ranged from -12.36 to 1179.5 (mean ± SD: 124.67 ± 243.79). 405 
There was no association between the time elapsed since the conditioning of the dogs in 406 
Experiment 1 and the expectancy scores (Pearson correlation test, r(20)=0.335 p=0.149). We 407 
revealed a significant positive relationship between the positive expectancy scores and 408 
placebo response values in case of the conditioned group (Pearson correlation test, r(12)= 0.697 409 
p = 0.008, Figure 6) but not in the control group (r(7)= 0.268 p = 0.521). 410 
These results indicate an association between ‘cognitive bias’ and ‘susceptibility to 411 
placebo conditioning’ measures in dogs, suggesting that dogs that have stronger positive 412 
expectancies (are more “optimistic”) tend to be more responsive to the stress relieving effects 413 
of placebo treatment after conditioning with an active substance. 414 
 415 
4. DISCUSSION 416 
 417 
 Our results provide the first behavioural evidence in dogs for the development of a 418 
conditioned placebo effect, an effect that is well-known in humans (Bendetti et al., 2003; 419 
Goebel et al., 2002) and in laboratory animals (Isaac and Isaac, 1976). In the two 420 
experimental groups (repeated treatment with sedative drug vs. non-sedating vitamin) we 421 
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observed opposite trends of changes in separation anxiety related behaviours. The effects of 422 
sedative drug conditioning manifested itself via increased passivity and decreased duration of 423 
behavioural signs of distress displayed close to the door. In contrast, dogs in the control group 424 
showed an opposite tendency in these responses. Considering that using a double dose of 425 
Acepromazine (compared to our design), Tontodonati et al. (2007) could not find any 426 
physiological or behavioural effects 16 hours after the treatment, long-term effects of 427 
acetylpromazin (Sedalin) are unlikely to explain the behaviour changes of the Conditioned 428 
group. 429 
Importantly, owners were present throughout the conditioning trials in order to avoid any 430 
possibility of creating direct association between the separation from the owner and the 431 
anxiolytic effects of Sedalin. During the conditioning trials dogs had the opportunity to learn 432 
about the ‘relaxed nature’ of the environment but they had no opportunity to learn how to 433 
cope with separation distress under the influence of Sedalin. This procedure was designed to 434 
eliminate the possibility that dogs develop reduced behaviour signs of distress as a 435 
conditioned response. In the test trial only one aspect of the conditioning environment was 436 
changed: the presence/absence of the owner. In this new context the associative memory 437 
traces regarding the anxiolytic effects of Sedalin could have been mediated by the procedural 438 
aspects of the placebo administration and/or by the cues of the testing environment. 439 
Our finding fits neatly into the placebo conditioning framework (McMillan 1999); therefore 440 
we assume that the repeated experience with the effects of Sedalin, as an unconditioned 441 
stimulus, could have resulted in the formation of a relaxed inner state, which was associated 442 
with some characteristic property of the pre-treatment procedure and/or with some 443 
environmental cues of the experimental set up as conditioned stimuli. As a result of this 444 
associative process, treatment procedure with the same features but without administration of 445 
Sedalin could reduce some behavioural signs of separation distress. It is worth mentioning 446 
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that we found no relevant differences between the Conditioned and Control groups in those 447 
episodes of Test trial in which the owner or the experimenter were present (Episodes 2 and 3). 448 
This suggests that the placebo effect, as a conditioned response, was specifically associated 449 
with the separation from the owner, despite the fact that separation anxiety was not triggered 450 
during conditioning trials where dogs were not separated. 451 
These findings are in line with the notion that a wide range of placebo phenomena, even in 452 
humans, is often nothing more than “contextual healing” (Miller and Kaptchuk, 2008; Di 453 
Blasi and Kleijnen, 2003) because, in addition to the medicine or treatment, the situational 454 
context of the healing (environmental cues and the ritual of the treatment) can also play a 455 
crucial role in the process (Kaptchuk, 2002). 456 
 The significant conditioning effect in the Sedalin group was evident even though our 457 
placebo conditioning method had some practical limitations. The liverwurst might not be an 458 
ideal specific signal for the sedative drug, and the late sedative effect might also impair the 459 
formation of an association. We hoped to overcome these potential problems using the water 460 
spray procedure. In fact, spraying the dogs’ muzzle and paws with water can be perceived as a 461 
salient and unusual stimulus event that could potentially be a key component of R-S learning 462 
during the conditioning phase, and thus a good mediator of the placebo effect. Using more 463 
stimuli, we cannot assess to what extent the different components of the treatment triggered 464 
the placebo effect, because any combination of them could be associated with the sedative 465 
state. The effect of the Sedalin gel could also vary among and even within subjects. 466 
Additionally, a relatively long time passed between the baseline and the test trials and there 467 
were relatively few, only three, conditioning trials (we should note that the number of trials 468 
affects the placebo-response in case of humans, see e.g. Colloca et al., 2010). Although 469 
owners had no preliminary information about which type of treatment their dogs received, we 470 
cannot exclude that they had some expectation regarding the treatment. However, since 471 
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owners were not present during the separation episode, this could have an indirect (if any) 472 
effect on the dogs’ behaviour. 473 
 Despite the above-mentioned potential confounding factors, our results provide strong 474 
support for the existence of a conditioned placebo effect in dogs because the assessment of the 475 
behavioural change was based on behaviour observations and not on the owners’ report (c.f. 476 
Munana et al., 2010; Jaeger et al., 2005; Cracknell and Mills, 2008). It is also worth 477 
mentioning that our findings concerning the conditioned placebo effect in alleviating 478 
separation anxiety have some veterinary implications and can be used to improve owners’ and 479 
their dogs’ daily life. Severe cases of separation anxiety often require the use of medications 480 
in addition to a behaviour modification program. Once the desired effect is achieved, the dose 481 
of the medicine may be gradually reduced and finally merely the procedure can maintain the 482 
effect. However, so far the administration method of the medicine has not been considered as 483 
important. Our results suggest that applying a specific regimen, that is, administrating the 484 
medicine always with the same environmental cues, for example with the same specific food 485 
type and with a set ritual, the real medicine can later be effectively replaced by placebo. As 486 
the anxiety relieving effect of placebo conditioning in dogs is of great applied importance, 487 
more research is needed to get a better perspective on the most efficient aspects of the 488 
treatment and the situational context that contributes to the manifestation of the placebo 489 
effect. 490 
 The results of Experiment 2 expand our knowledge on placebo conditioning in dogs 491 
and highlight the potential importance of expectancy bias on the formation of placebo 492 
responses. The finding that dogs that were more responsive to the placebo treatment tended to 493 
show stronger positive expectancy in an ambivalent situation seems to be consistent with the 494 
conclusions of human studies (Geers et al., 2005; 2007; 2010; Morton et al., 2009). 495 
Importantly however, these human studies investigated the expectancy based and not the 496 
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conditioned placebo effect. Although it remains unclear whether conscious learning (Stewart-497 
Williams and Podd, 2004; Kirsch, 1985) or some ‘cognitively blind’ physiological response 498 
plays a more prominent role in the observed placebo effect, the association between dogs’ 499 
positive expectancy scores and the magnitude of placebo-induced responses suggests that the 500 
observed placebo effect could not be entirely explained by unconscious factors.  501 
 In sum, the combined results of the two experiments open the door for studying the 502 
mechanism of placebo responses in the dog in its own right and provide further support for 503 
the validity of the application of the dog as a model species towards a better understanding of 504 
some aspects of the placebo phenomena in humans. 505 
 506 
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Table 1 626 
  Baseline trial  
Conditioning  
(trials 2-4) 
Test trial   
Conditioned 
group (N=14) 
Separation  
No pre-treatment 
No separation  
Sedative pre-
treatment (Sedalin) 
Water spray 
Separation  
Non-sedating pre-
treatment 
(vitamin) 
Water spray 
Control group 
(N=14) 
No separation  
Non-sedating pre-
treatment (vitamin) 
Water spray 
 627 
Table 1. Experimental design of Experiment 1. 628 
All types of pre-treatments contained the additional water spraying and a piece of liverwurst 629 
right before the trials. 630 
 631 
 632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
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Table 2 640 
 GEE analysis (based on raw data) 
Mann-Whiney test 
(change from 
baseline to test trial) 
 
trial (baseline 
vs. test) 
treatment group 
(conditioned vs. 
control) 
trial x treatment 
interaction 
conditioned vs. 
control group 
D/distr-A 
χ2=0.001, 
p=0.985 
χ2=0.481, 
p=0.488 
χ2=4.66, p=0.031 U(26)=48, p=0.021 
PASS-A 
χ2=0.356, 
p=0.551 
χ2=0.016, 
p=0.901 
χ2=6.537, 
p=0.011 
U(26)=50, p=0.027 
D/PASS-
A 
χ2=0.239, 
p=0.625 
χ2=0.017, 
p=0.896 
χ2=1, p=0.317 U(26)=79, p=0.401 
 641 
Table 2. Summary of the statistical analyses (separation episode, Experiment 1).  642 
  643 
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Figure captions 644 
 645 
Figure 1. Schematic layout of the experimental arrangement in Experiment 1.  646 
A chair and some toys were present in the experimental room. Door 1 was used by the 647 
stranger to enter; Door 2 was used by the owner to enter. The areas near the door are indicated 648 
with broken lines. SP & OP were places marked with adhesive tape on the floor where the 649 
stranger (SP) and the owner (OP) stood (see Procedure). 650 
 651 
 652 
 653 
 654 
 655 
 656 
 657 
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Figure 2. Relative duration of passive behaviours in Episode 1  658 
Dogs in the two groups showed different changes in passive behaviour after the conditioning. 659 
* indicates significant (p < 0.05) trial (Baseline vs. Test) x treatment (administering Sedalin 660 
vs. vitamin) interaction. 661 
 662 
 663 
 664 
 665 
 666 
 667 
 668 
 669 
 670 
 671 
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Figure 3. Relative duration of distress close to the door in Episode 1  672 
Dogs in the two groups showed different changes in distress signs close to the door after the 673 
conditioning. * indicates significant (p < 0.05) trial (Baseline vs. Test) x treatment 674 
(administering Sedalin vs. vitamin) interaction. 675 
 676 
 677 
 678 
 679 
 680 
 681 
 682 
 683 
 684 
 685 
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Figure 4. Difference values of sign of distress close to the door 686 
Dogs in the Conditioned group have higher difference scores (compared to the Control 687 
group), which represent higher placebo response (higher change in distress). * indicates 688 
significant (p < 0.05) between group difference (median+quartiles+outlier data). 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
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Figure 5. Experiment 2: Arrangement of the cognitive bias test. 698 
The experimenter standing behind the dog and the owner baited (or did not bait, depending on 699 
trial type) a plastic pot with a piece of sausage. Then she placed the food bowl at one of three 700 
pre‐determined locations (negative, ambivalent, positive), then she went behind the owner, 701 
and the dog was released to approach the bowl. 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
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 710 
Figure 6. Relationship between the individual placebo response and positive expectancy 711 
There is a logarithmic relationship between the positive expectancy scores and the placebo 712 
response values (r=0.697 p=0.008) in the conditioned group. 713 
 714 
